QuidelOrtho EBITDA Margin 2010-2024 | QDEL
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for QuidelOrtho (QDEL) over the last 10 years. The current EBITDA margin for QuidelOrtho as of December 31, 2024 is .
| QuidelOrtho EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-09-30 | $2.82B | $0.38B | 13.59% |
| 2024-06-30 | $2.84B | $0.39B | 13.90% |
| 2024-03-31 | $2.86B | $0.48B | 16.87% |
| 2023-12-31 | $3.00B | $0.60B | 19.88% |
| 2023-09-30 | $3.12B | $0.64B | 20.63% |
| 2023-06-30 | $3.16B | $0.67B | 21.07% |
| 2023-03-31 | $3.11B | $0.71B | 22.68% |
| 2022-12-31 | $3.27B | $1.13B | 34.52% |
| 2022-09-30 | $3.04B | $1.32B | 43.35% |
| 2022-06-30 | $2.76B | $1.45B | 52.50% |
| 2022-03-31 | $2.33B | $1.36B | 58.34% |
| 2021-12-31 | $1.70B | $0.96B | 56.44% |
| 2021-09-30 | $1.87B | $1.19B | 63.66% |
| 2021-06-30 | $1.84B | $1.22B | 66.30% |
| 2021-03-31 | $1.86B | $1.28B | 68.80% |
| 2020-12-31 | $1.66B | $1.11B | 66.73% |
| 2020-09-30 | $1.01B | $0.53B | 53.03% |
| 2020-06-30 | $0.66B | $0.25B | 37.56% |
| 2020-03-31 | $0.56B | $0.17B | 30.30% |
| 2019-12-31 | $0.53B | $0.15B | 28.09% |
| 2019-09-30 | $0.52B | $0.14B | 27.96% |
| 2019-06-30 | $0.51B | $0.16B | 32.21% |
| 2019-03-31 | $0.50B | $0.13B | 26.75% |
| 2018-12-31 | $0.52B | $0.16B | 29.89% |
| 2018-09-30 | $0.50B | $0.14B | 26.79% |
| 2018-06-30 | $0.44B | $0.09B | 19.63% |
| 2018-03-31 | $0.37B | $0.09B | 24.13% |
| 2017-12-31 | $0.28B | $0.05B | 17.27% |
| 2017-09-30 | $0.22B | $0.04B | 18.52% |
| 2017-06-30 | $0.21B | $0.04B | 20.56% |
| 2017-03-31 | $0.22B | $0.05B | 21.86% |
| 2016-12-31 | $0.19B | $0.03B | 13.09% |
| 2016-09-30 | $0.19B | $0.02B | 11.58% |
| 2016-06-30 | $0.19B | $0.02B | 11.17% |
| 2016-03-31 | $0.18B | $0.02B | 10.33% |
| 2015-12-31 | $0.20B | $0.03B | 15.82% |
| 2015-09-30 | $0.21B | $0.04B | 20.10% |
| 2015-06-30 | $0.20B | $0.03B | 15.27% |
| 2015-03-31 | $0.20B | $0.03B | 15.08% |
| 2014-12-31 | $0.18B | $0.02B | 10.33% |
| 2014-09-30 | $0.17B | $0.01B | 2.92% |
| 2014-06-30 | $0.16B | $0.01B | 5.49% |
| 2014-03-31 | $0.16B | $0.01B | 6.75% |
| 2013-12-31 | $0.18B | $0.03B | 16.85% |
| 2013-09-30 | $0.18B | $0.05B | 25.00% |
| 2013-06-30 | $0.18B | $0.05B | 26.82% |
| 2013-03-31 | $0.18B | $0.05B | 28.33% |
| 2012-12-31 | $0.16B | $0.03B | 21.15% |
| 2012-09-30 | $0.14B | $0.02B | 13.57% |
| 2012-06-30 | $0.14B | $0.02B | 13.57% |
| 2012-03-31 | $0.14B | $0.02B | 11.68% |
| 2011-12-31 | $0.16B | $0.03B | 19.50% |
| 2011-09-30 | $0.15B | $0.03B | 16.99% |
| 2011-06-30 | $0.15B | $0.02B | 14.86% |
| 2011-03-31 | $0.15B | $0.02B | 13.79% |
| 2010-12-31 | $0.11B | $-0.00B | -2.65% |
| 2010-09-30 | $0.15B | $0.03B | 18.92% |
| 2010-06-30 | $0.18B | $0.05B | 30.68% |
| 2010-03-31 | $0.18B | $0.06B | 34.09% |
| 2009-12-31 | $0.17B | $0.06B | 35.76% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $2.832B | $2.998B |
| QuidelOrtho is a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems. The company's brand names include Sofia(R), Solana(R), Lyra(R), Triage(R) and QuickVue(R). Its comprehensive product portfolio includes tests for a range of infectious diseases, cardiac and autoimmune biomarkers, as well as a host of products to detect COVID-19. QuidelOrtho, formerly known as Quidel Corporation, is based in SAN DIEGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $222.392B | 27.46 |
| Boston Scientific (BSX) | United States | $154.781B | 41.84 |
| Stryker (SYK) | United States | $150.988B | 32.49 |
| EssilorLuxottica (ESLOY) | France | $128.761B | 0.00 |
| Medtronic (MDT) | Ireland | $116.457B | 17.30 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.724B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.049B | 27.97 |
| Agilent Technologies (A) | United States | $42.120B | 27.91 |
| GE HealthCare Technologies (GEHC) | United States | $40.456B | 20.98 |
| ResMed (RMD) | United States | $34.834B | 26.83 |
| Terumo (TRUMY) | Japan | $27.701B | 39.39 |
| Koninklijke Philips (PHG) | Netherlands | $25.801B | 19.75 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.443B | 12.84 |
| Insulet (PODD) | United States | $20.179B | 80.36 |
| Baxter (BAX) | United States | $15.731B | 10.24 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.039B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.976B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.951B | 37.15 |
| Bio-Rad Laboratories (BIO) | United States | $9.670B | 32.87 |
| Demant (WILYY) | Denmark | $7.946B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.320B | 14.69 |
| Prestige Consumer Healthcare (PBH) | United States | $4.316B | 20.65 |
| ICU Medical (ICUI) | United States | $3.878B | 36.92 |
| Envista Holdings (NVST) | United States | $3.750B | 29.85 |
| Perrigo (PRGO) | Ireland | $3.407B | 10.03 |
| Haemonetics (HAE) | United States | $3.164B | 14.89 |
| GN Store Nord (GNNDY) | Denmark | $3.123B | 21.05 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $2.989B | 0.00 |
| Neogen (NEOG) | United States | $2.315B | 26.67 |
| LeMaitre Vascular (LMAT) | United States | $2.245B | 54.55 |
| AtriCure (ATRC) | United States | $1.997B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.513B | 26.48 |
| AdaptHealth (AHCO) | United States | $1.300B | 9.29 |
| InMode (INMD) | Israel | $1.269B | 10.61 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.250B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.215B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.069B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.996B | 15.27 |
| Evolus (EOLS) | United States | $0.849B | 0.00 |
| CeriBell (CBLL) | United States | $0.810B | 0.00 |
| Owens & Minor (OMI) | United States | $0.667B | 5.21 |
| Capricor Therapeutics (CAPR) | United States | $0.652B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.627B | 27.14 |
| Valneva SE (VALN) | France | $0.563B | 0.00 |
| Omeros (OMER) | United States | $0.526B | 0.00 |
| SNDL (SNDL) | Canada | $0.507B | 0.00 |
| Surmodics (SRDX) | United States | $0.487B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.474B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.424B | 0.00 |
| ZimVie (ZIMV) | United States | $0.383B | 32.26 |
| Canopy Growth (CGC) | Canada | $0.363B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.343B | 62.50 |
| Cerus (CERS) | United States | $0.323B | 0.00 |
| Quanterix (QTRX) | United States | $0.320B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.317B | 30.11 |
| Sanara MedTech (SMTI) | United States | $0.309B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.292B | 19.55 |
| Biote (BTMD) | United States | $0.261B | 5.73 |
| Zynex (ZYXI) | United States | $0.252B | 52.80 |
| High Tide (HITI) | Canada | $0.238B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.232B | 3.26 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.226B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.209B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.209B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.203B | 15.16 |
| Brainsway (BWAY) | Israel | $0.200B | 106.40 |
| MacroGenics (MGNX) | United States | $0.174B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.164B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.142B | 17.83 |
| Jin Medical (ZJYL) | China | $0.130B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.127B | 0.00 |
| Fonar (FONR) | United States | $0.101B | 11.44 |
| Exagen (XGN) | United States | $0.093B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Veru (VERU) | United States | $0.085B | 0.00 |
| InterCure (INCR) | Israel | $0.080B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.073B | 0.00 |
| INLIF (INLF) | $0.067B | 0.00 | |
| Rockwell Medical (RMTI) | United States | $0.064B | 33.00 |
| Cytosorbents (CTSO) | United States | $0.057B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.055B | 0.00 |
| Apyx Medical (APYX) | United States | $0.052B | 0.00 |
| MariMed (MRMD) | United States | $0.051B | 0.00 |
| United-Guardian (UG) | United States | $0.051B | 14.60 |
| Modular Medical (MODD) | United States | $0.048B | 0.00 |
| ImmuCell (ICCC) | United States | $0.048B | 0.00 |
| Safety Shot (SHOT) | United States | $0.035B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.012B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Agape ATP (ATPC) | $0.005B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |